Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - MusclePharm Corp | d103625dex311.htm |
EX-31.2 - EX-31.2 - MusclePharm Corp | d103625dex312.htm |
EX-32.2 - EX-32.2 - MusclePharm Corp | d103625dex322.htm |
EX-32.1 - EX-32.1 - MusclePharm Corp | d103625dex321.htm |
EX-10.17 - EX-10.17 - MusclePharm Corp | d103625dex1017.htm |
EX-10.15 - EX-10.15 - MusclePharm Corp | d103625dex1015.htm |
EX-10.14 - EX-10.14 - MusclePharm Corp | d103625dex1014.htm |
EX-10.16 - EX-10.16 - MusclePharm Corp | d103625dex1016.htm |
10-K - 10-K - MusclePharm Corp | d103625d10k.htm |
Exhibit 21
To
Annual Report
Form 10-K
For the Year ended December 31, 2015
Subsidiaries of the Registrant
Bio Zone Laboratories, Inc. (2014) Nevada Corporation
Canada MusclePharm Enterprises Corporation (2012) Ontario, Canada Registered
MP Holding Ireland, LLC (2014) Delaware LLC
MusclePharm Holdings Ireland (2014) Ireland Registration Isle of Man Managed Company
MusclePharm Ireland (2014) Ireland Registration
MP DO Brazil Acquistion, LLC (2014) Delaware LLC
MusclePharm Australia PTY LTD (2015) Australian Registration